Sanofi-Aventis, the French pharmaceuticals company, is gearing up for acquisitions to expand and diversify operations under its new chief executive.

In the wake of Pfizer’s $68bn takeover of Wyeth last week, Sanofi-Aventis has held talks with bankers about possible deals.